Applause sign in Parkinsonian disorders and Huntington's disease

Laura Wu, Oraporn Sitburana, Anthony Davidson, Joseph Jankovic

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The applause sign has been previously reported to be indicative of neurodegenerative disorders, such as progressive supranuclear palsy (PSP). In order to determine the sensitivity, specificity, and positive predictive value, we tested it in patients with PSP, Parkinson's disease (PD), multiple system atrophy (MSA), corticobasal degeneration (CBD), and Huntington's disease (HD). Subjects were asked to clap three times after demonstration by the examiner. The performance was scored as follows: 3 5 claps only three times; 2 = claps four times; 1 = claps 5 to 10 times; 0 = claps >10 times. The clap test was videotaped and rated. Patients with CBD, MSA, and PSP showed significant differences in clap scores compared with normal controls. The test differentiated patients with CBD from those with PD (P < 0.005) and HD (P < 0.005), but failed to discriminate patients with PSP from other parkinsonian groups. The specificity of the applause sign is 100% in distinguishing parkinsonian patients from normal subjects with the highest sensitivity in CBD patients. We concluded that the applause sign is highly specific for parkinsonian disorders but it is not a specific sign for PSP; it appears to be most sensitive for CBD.

Original languageEnglish (US)
Pages (from-to)2307-2311
Number of pages5
JournalMovement Disorders
Volume23
Issue number16
DOIs
StatePublished - Dec 15 2008
Externally publishedYes

Fingerprint

Huntington Disease
Progressive Supranuclear Palsy
Parkinsonian Disorders
Multiple System Atrophy
Parkinson Disease
Neurodegenerative Diseases
Sensitivity and Specificity

Keywords

  • Applause sign
  • Huntington's disease
  • Multiple system atrophy
  • Parkinson's disease
  • Progressive supranuclear palsy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Applause sign in Parkinsonian disorders and Huntington's disease. / Wu, Laura; Sitburana, Oraporn; Davidson, Anthony; Jankovic, Joseph.

In: Movement Disorders, Vol. 23, No. 16, 15.12.2008, p. 2307-2311.

Research output: Contribution to journalArticle

Wu, L, Sitburana, O, Davidson, A & Jankovic, J 2008, 'Applause sign in Parkinsonian disorders and Huntington's disease', Movement Disorders, vol. 23, no. 16, pp. 2307-2311. https://doi.org/10.1002/mds.22090
Wu, Laura ; Sitburana, Oraporn ; Davidson, Anthony ; Jankovic, Joseph. / Applause sign in Parkinsonian disorders and Huntington's disease. In: Movement Disorders. 2008 ; Vol. 23, No. 16. pp. 2307-2311.
@article{0e18cd76bb094bbcbe43ac359ca93ee6,
title = "Applause sign in Parkinsonian disorders and Huntington's disease",
abstract = "The applause sign has been previously reported to be indicative of neurodegenerative disorders, such as progressive supranuclear palsy (PSP). In order to determine the sensitivity, specificity, and positive predictive value, we tested it in patients with PSP, Parkinson's disease (PD), multiple system atrophy (MSA), corticobasal degeneration (CBD), and Huntington's disease (HD). Subjects were asked to clap three times after demonstration by the examiner. The performance was scored as follows: 3 5 claps only three times; 2 = claps four times; 1 = claps 5 to 10 times; 0 = claps >10 times. The clap test was videotaped and rated. Patients with CBD, MSA, and PSP showed significant differences in clap scores compared with normal controls. The test differentiated patients with CBD from those with PD (P < 0.005) and HD (P < 0.005), but failed to discriminate patients with PSP from other parkinsonian groups. The specificity of the applause sign is 100{\%} in distinguishing parkinsonian patients from normal subjects with the highest sensitivity in CBD patients. We concluded that the applause sign is highly specific for parkinsonian disorders but it is not a specific sign for PSP; it appears to be most sensitive for CBD.",
keywords = "Applause sign, Huntington's disease, Multiple system atrophy, Parkinson's disease, Progressive supranuclear palsy",
author = "Laura Wu and Oraporn Sitburana and Anthony Davidson and Joseph Jankovic",
year = "2008",
month = "12",
day = "15",
doi = "10.1002/mds.22090",
language = "English (US)",
volume = "23",
pages = "2307--2311",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "16",

}

TY - JOUR

T1 - Applause sign in Parkinsonian disorders and Huntington's disease

AU - Wu, Laura

AU - Sitburana, Oraporn

AU - Davidson, Anthony

AU - Jankovic, Joseph

PY - 2008/12/15

Y1 - 2008/12/15

N2 - The applause sign has been previously reported to be indicative of neurodegenerative disorders, such as progressive supranuclear palsy (PSP). In order to determine the sensitivity, specificity, and positive predictive value, we tested it in patients with PSP, Parkinson's disease (PD), multiple system atrophy (MSA), corticobasal degeneration (CBD), and Huntington's disease (HD). Subjects were asked to clap three times after demonstration by the examiner. The performance was scored as follows: 3 5 claps only three times; 2 = claps four times; 1 = claps 5 to 10 times; 0 = claps >10 times. The clap test was videotaped and rated. Patients with CBD, MSA, and PSP showed significant differences in clap scores compared with normal controls. The test differentiated patients with CBD from those with PD (P < 0.005) and HD (P < 0.005), but failed to discriminate patients with PSP from other parkinsonian groups. The specificity of the applause sign is 100% in distinguishing parkinsonian patients from normal subjects with the highest sensitivity in CBD patients. We concluded that the applause sign is highly specific for parkinsonian disorders but it is not a specific sign for PSP; it appears to be most sensitive for CBD.

AB - The applause sign has been previously reported to be indicative of neurodegenerative disorders, such as progressive supranuclear palsy (PSP). In order to determine the sensitivity, specificity, and positive predictive value, we tested it in patients with PSP, Parkinson's disease (PD), multiple system atrophy (MSA), corticobasal degeneration (CBD), and Huntington's disease (HD). Subjects were asked to clap three times after demonstration by the examiner. The performance was scored as follows: 3 5 claps only three times; 2 = claps four times; 1 = claps 5 to 10 times; 0 = claps >10 times. The clap test was videotaped and rated. Patients with CBD, MSA, and PSP showed significant differences in clap scores compared with normal controls. The test differentiated patients with CBD from those with PD (P < 0.005) and HD (P < 0.005), but failed to discriminate patients with PSP from other parkinsonian groups. The specificity of the applause sign is 100% in distinguishing parkinsonian patients from normal subjects with the highest sensitivity in CBD patients. We concluded that the applause sign is highly specific for parkinsonian disorders but it is not a specific sign for PSP; it appears to be most sensitive for CBD.

KW - Applause sign

KW - Huntington's disease

KW - Multiple system atrophy

KW - Parkinson's disease

KW - Progressive supranuclear palsy

UR - http://www.scopus.com/inward/record.url?scp=61449240279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449240279&partnerID=8YFLogxK

U2 - 10.1002/mds.22090

DO - 10.1002/mds.22090

M3 - Article

VL - 23

SP - 2307

EP - 2311

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 16

ER -